Search research articles
Contact Us
Filters
Showing results (291-300 of 341) with videos related to
Page
of 35
Sort By:
United European Gastroenterology Journal
|
October 5, 2024
Defining mucosal healing in randomized controlled trials of inflammatory bowel disease: A systematic review and future perspective
Tommaso Lorenzo Parigi, Virginia Solitano, Alessandro Armuzzi, et al.
Therapeutic Advances in Gastroenterology
|
September 22, 2017
Clinical performance of an infliximab rapid quantification assay
Fernando Magro, Joana Afonso, Susana Lopes, et al.
Nature Reviews. Gastroenterology & Hepatology
|
April 22, 2025
Shaping the future of inflammatory bowel disease: a global research agenda for better management and public health response
Virginia Solitano, Charles N Bernstein, Iris Dotan, et al.
Journal of Crohn'S & Colitis
|
August 12, 2025
Longitudinal Profiles of Fecal Calprotectin and C-Reactive Protein in Relation to Outcomes in Crohn's Disease Patients on Infliximab
Fernando Magro, Beatriz Domingues, Maria Manuela Estevinho, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 13, 2021
Subclinical Persistent Inflammation as Risk Factor for Crohn's Disease Progression: Findings From a Prospective Real-World Study of 2 Years
Fernando Magro, Diogo Magalhães, Marta Patita, et al.
Autoimmunity Reviews
|
December 21, 2023
Implementation of regulatory guidance for JAK inhibitors use in patients with immune-mediated inflammatory diseases: An international appropriateness study
Virginia Solitano, Paola Facheris, Magnus Petersen, et al.
Journal of Crohn'S & Colitis
|
January 20, 2024
The Influence of Subclinical Active Inflammation on IFX Pharmacokinetic Modeling and Disease Progression Assessment: Findings from a Prospective Real-World Study in Inflammatory Bowel Disease Patients
Fernando Magro, Samuel Fernandes, Marta Patita, et al.
Journal of Crohn'S & Colitis
|
June 21, 2011
Construction and validation of a web-based epidemiological database for inflammatory bowel diseases in Europe An EpiCom study
Johan Burisch, Silvija Cukovic-Cavka, Ioannis Kaimakliotis, et al.
Ebiomedicine
|
June 21, 2017
Calprotectin and the Magnitude of Antibodies to Infliximab in Clinically-stable Ulcerative Colitis Patients are More Relevant Than Infliximab Trough Levels and Pharmacokinetics for Therapeutic Escalation
Fernando Magro, Joana Afonso, Susana Lopes, et al.
United European Gastroenterology Journal
|
June 15, 2023
How many biomarker measurements are needed to predict prognosis in Crohn's disease patients under infliximab?-A prospective study
Fernando Magro, Maria Manuela Estevinho, Gaia Catalano, et al.
Page
of 35
Search research articles
Search
Showing results (291-300 of 341) with videos related to
Sort By:
Page
of 35
United European Gastroenterology Journal
|
October 5, 2024
Defining mucosal healing in randomized controlled trials of inflammatory bowel disease: A systematic review and future perspective
Tommaso Lorenzo Parigi, Virginia Solitano, Alessandro Armuzzi, et al.
Therapeutic Advances in Gastroenterology
|
September 22, 2017
Clinical performance of an infliximab rapid quantification assay
Fernando Magro, Joana Afonso, Susana Lopes, et al.
Nature Reviews. Gastroenterology & Hepatology
|
April 22, 2025
Shaping the future of inflammatory bowel disease: a global research agenda for better management and public health response
Virginia Solitano, Charles N Bernstein, Iris Dotan, et al.
Journal of Crohn'S & Colitis
|
August 12, 2025
Longitudinal Profiles of Fecal Calprotectin and C-Reactive Protein in Relation to Outcomes in Crohn's Disease Patients on Infliximab
Fernando Magro, Beatriz Domingues, Maria Manuela Estevinho, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 13, 2021
Subclinical Persistent Inflammation as Risk Factor for Crohn's Disease Progression: Findings From a Prospective Real-World Study of 2 Years
Fernando Magro, Diogo Magalhães, Marta Patita, et al.
Autoimmunity Reviews
|
December 21, 2023
Implementation of regulatory guidance for JAK inhibitors use in patients with immune-mediated inflammatory diseases: An international appropriateness study
Virginia Solitano, Paola Facheris, Magnus Petersen, et al.
Journal of Crohn'S & Colitis
|
January 20, 2024
The Influence of Subclinical Active Inflammation on IFX Pharmacokinetic Modeling and Disease Progression Assessment: Findings from a Prospective Real-World Study in Inflammatory Bowel Disease Patients
Fernando Magro, Samuel Fernandes, Marta Patita, et al.
Journal of Crohn'S & Colitis
|
June 21, 2011
Construction and validation of a web-based epidemiological database for inflammatory bowel diseases in Europe An EpiCom study
Johan Burisch, Silvija Cukovic-Cavka, Ioannis Kaimakliotis, et al.
Ebiomedicine
|
June 21, 2017
Calprotectin and the Magnitude of Antibodies to Infliximab in Clinically-stable Ulcerative Colitis Patients are More Relevant Than Infliximab Trough Levels and Pharmacokinetics for Therapeutic Escalation
Fernando Magro, Joana Afonso, Susana Lopes, et al.
United European Gastroenterology Journal
|
June 15, 2023
How many biomarker measurements are needed to predict prognosis in Crohn's disease patients under infliximab?-A prospective study
Fernando Magro, Maria Manuela Estevinho, Gaia Catalano, et al.
Page
of 35